Bruno David
Lourenço Paiva
Ikertzailea 2011-2015 tartean
University of Chicago Medical Center
Chicago, Estados UnidosUniversity of Chicago Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
-
Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE
Blood, Vol. 139, Núm. 4, pp. 492-501
2020
-
First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Clinical Cancer Research, Vol. 26, Núm. 10, pp. 2308-2317